Summary
The immunoregulatory cytokine interleukin 6 (1176) directly upregulates production of human immunodeficiency virus (HIV) in acutely as well as in chronically infected cells of monocytic lineage. In addition, 11,6 synergizes with tumor necrosis factor a (TNF-a) in the induction of latent HIV expression. Unlike TNF-a, upregulation ofviral expression induced by IL6 alone does not occur at the transcriptional level and it is not associated with accumulation of HIV RNA . However, when IM and TNF-ci synergistically stimulate HIV production, accumulation of HIV RNA and increased transcription are observed, indicating that IM affects HIV expression at multiple (transcriptional and post-transcriptional) levels. H IV, the causative agent of AIDS, can infect and persist in the CD4+ cells of the immune system, such as T lymphocytes and mononuclear phagocytes (1) . A number of mechanisms have been recently delineated whereby virus ex pression is upregulated in infected cells (reviewed in reference 1) . Of particular interest is the fact that the virus can utilize a number of cell-derived soluble factors or cytokknns for this purpose. In this regard, it has recently been demonstrated that cytokine-rich crude supernatants ofmononuclear cells (2, 3) , as well as recombinant cytokines such as TNF-a (4, 5) and -ß (4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)t (2, 6) , can induce expression of virus in HIVinfected cells. It is noteworthy that this virus, which utilizes a functionally important molecule (CD4) on the surface of immune competent target cells as its receptor for cell entry (7) , has also evolved cellular mechanisms for the upregulation of its expression by certain cytokines operative in thenormal homeostatic control ofthe immune system. Furthermore, the molecular pathway(s) whereby HIV upregulation is accomplished for certain cytokines such as TNF is similar to the molecular mechanisms that modulate the expression of cellular gene function (8, 9) . Specifically, TNF ' Abbreviations used in this paper. Ab, antibody ; GM-CSF, granulocyte/ macrophage colony-stimulating factor; HTLV--1, human T lymphotropic virus 1; IMDM, Iscove's modified Dulbecco's medium; LTR, long terminal repeat; MDM, monocyte-derived macrophages; RT, reverse transcriptase. induction of HIV expression utilizes the pleiotropic cellular transcription factor NF-kB (9), which binds to the core enhancer region ofthe HIV long terminal repeat (LTR) (10-13) .
Ofparticular interest in the human immunoregulatory network is the cytokine IL-6, which has a broad range of effects on the regulation of the immune system (14, 15) . IL-6 is also known as B cell stimulatory factor 2 (16), hybridoma/plasmacytoma growth factor (17), hepatocyte-stimulating factor (18) , , and 26kD protein (20) . Synthesis of 1176 is inducible in many cell types (reviewed in references 14 and 15), including mononuclear phagocytes and T lymphocytes . Among the several conditions whereby synthesis of IL6 is induced, infection of T lymphocytes with the human T lymphotropic virus 1 (HTLV1) (20) , and cell stimulation by cytokknns such TNF-cY (21) and ILA (22) , are of particular interest . Among its several functions (14, 15) , 1176 induces terminal differentiation of lymphocytes to plasma cells (23) and proliferation of precursor and mature T cells (24) , and acts as an autocrine growth factor for multiple myelomas/ plasmacytomas (25, 26) .
With regard to the relationship of this cytokine to HIV, in vitro infection of normal monocyte/macrophages with HIV-1 has been found to induce gene expression and secretion of 11,6 (27) . In addition, increased levels of IL6 have been recently reported both in the serum (28) and in the cerebrospinal fluid (29) of HIV-infected patients . Thus, it is important to determine whether this cytokine is capable of directly affecting the expression ofHIV in infected cells and/or of modulating the inducibility of this virus in response to other cytokines.
In the present study we demonstrate that 11,6 directly stimulates HIV replication in primary human macrophages acutely infected in vitro. In addition, 11.,6 induces HIV expression in chronically infected promonocytic cells and synergizes with TNF-a in this effect. Furthermore, at the molecular level, we provide evidence that IIr6 induction of HIV expression involves multiple and diverse mechanisms.
Materials and Methods
Infection ofPrimary Monocyte-derived Macrophages (MD*. Heparinized venous peripheral blood from healthy seronegative donors was diluted 1:4 with cold PBS and subjected to Ficoll-Hypaque gradient (550 g for 30 min at 4°C) in order to separate the mononuclear cell fraction (PBMC). PBMC were carefully resuspended in cold PBS and washed twice (350 g for 10 min at 4°C) in order to reduce platelet contamination. Finally, PBMC were resuspended in Iscove's Modified Dulbecco's Medium (IMDM; Gibco Laboratories, Grand Island, NY) containing 10% FCS (basic medium). The bacterial endotoxin (LPS) content of the medium and FCS was <3 pg/ml, and <400 pg/ml, respectively. Then, N2 x 10, cells/ ml/well were plated in 24-well plastic tissue culture plates (Costar, Cambridge, MA). After overnight incubation at 37°C in humidified, 5% CO2 atmosphere, nonadherent cells (highly enriched in T lymphocytes) were removed by vigorous pipetting. The remaining adherent cells (predominantly monocytes) were maintained in culture in the presence or absence of 100 U/ml of rIL6, or TNF-cY, or GM-CSF for an additional 5-7 d before infection with a macrophage-tropic strain of HIV (AD-87) (30) . The LPS contents of these cytokine concentrations were <0 .1 pg/ml. No significant differences in comparison to adherence-purified monocytes were observed when monocytes were purified by countercurrent centrifugal elutriation and infected with HIV Approximately 50% of the culture supernatants was replaced with basic medium or medium containing cytokines every 5-7 d after HIV infection for several weeks. In parallel experiments, the autologous nonadherent (T lymphocyte-enriched) cells were maintained and infected with HIV in similar culture conditions. PHAstimulated T cell blasts were also infected with a T lymphocytotropic HIV strain (LAV) and. were maintained in culture in medium containing IIr2 (31) plus additional cytokines.
HIVinfected Cell Lines. The chronically HIVinfected Ul cell line was obtained by limiting dilution cloning of promonocytic U937 cells that survived an acute HIV-1 infection (32) . U1 cells possess two integrated copies of HIV proviral DNA (Maury W., and A. Rabson, personal communication) and constitutively express low levels of virus as determined by immunofluorescence, cellular and supernatant-associated reverse transcriptase (KT) activity, HIV p24 antigen capture, Western blot and Northern blot analysis (32) (33) (34) . Upregulation of HIV expression in U1 cells is induced by PMA (32), cytokine-enriched supernatants (2), and recombinant cytokines such as TNF-a (34, 35) , and GM-CSF (2). In addition, a second chronically infected clone of U937, U33.3 (34) , and the chronically infected CEM-derived ACH-2 T lymphocytic cell line (3, 34, 36) , which are also inducible by PMA and TNF-a, were tested in response to 11,6 . Cytokines and Anticytokine Antibodies (Abp Various cell lines were stimulated with recombinant human (rh) IL6 (Amgen Biologicals, Thousands Oaks, CA), rhTNF-a, and rhGM-CSF (Genzyme Corp ., Boston, MA) in a concentration range between 0.1 and 1,000 U/ml . Typically, 2.5 x 101 cells/ml were resuspended in RPMI 1640 (M . A. Whitaker Bioproducts, Walkersville, MD) containing 10% FCS, plated in 24-or 96-well plates (Costar) in the presence or absence of cytokines, and were maintained at 37°C in 5% C0 2. Aliquots of the culture supernatants were harvested daily up to 6 d after stimulation, stored at -70°C, thawed, and tested for RT activity. Goat polyclonal and murine monoclonal anti-IL6 Ab (R & D System, Minneapolis, MN) were tested for their ability to suppress the induction of HIV production by various cytokines. Rabbit polyclonal antiTNF-a Ab (a kind gift of Dr. Renato Bernardini, University of Catania, Italy, and Samuel Listwak, NIMH, NIH, Bethesda, MD), and monoclonal antiTNF-a Ab (Olympus, Lake Success, NY) were also tested for their ability to suppress HIV expression.
RT Assay. Aliquots of supernatants from cytokine-stimulated and unstimulated cultures were tested for the presence of HIV RT by the method of Willey et al . (37) . 10 Al of supernatants were added in duplicate to 50 Al of a mixture containing poly(A), oligo(dT) (Pharmacia Fine Chemicals, Piscataway, NJ), MgCl 2, and '2P-labeled deoxythymidine 5'-triphosphate (dTTP) (Amersham Corp., Arlington Heights, IL), and incubated for 2 h at 37°C. 6 EAl of the mixture was spotted onto DE81 paper (Whatman International, Maidston, England), air-dried, washed five times in 2 x SSC buffer, and two additional times in 95% ethanol. The paper was then dried, cut, and counted on a scintillation counter (No. LS 7000; Beckman Instruments, Fullerton, CA).
Western Blot Analysis. Cell lysates were prepared from Ul cells incubated for 72 h in the presence or absence of 100 U/ml of IL6, 100 U/ml of TNF-a, or the combination of both cytokines. 20 141 from the lysate of 10' cells was added to each lane and subjected to electrophoresis through 10-20% gradient polyacrylamide gels (Integration Separation Sciences, Hyde Park, MA) for 6 h. The migrated proteins were then transferred overnight onto nitrocellulose filters. After saturation with a 5% milk solution, filters were incubated for 2 h with 1 :1,000 vol/vol dilution of an AIDS patient serum containing high titers of anti-HIV Ab recognizing most of the major viral proteins (33) . Filters were then washed and incubated for 90 min with "II-labeled protein A (200,000 dpm/ml), washed, air-dried, and exposed overnight to x-ray film, as previously described (33) .
Northern Blot Analysis. Ul cells were resuspended at 2.5 x 101 cells/ml and maintained in RPMI 1640 with 10% FCS in the presence or absence of various cytokines. Total RNA was extracted by the guanidine thiocyanate phenol method with an RNA Isolation Kit (Stratagene, La Jolla, CA) from 108 Ul cells after 24, 48, and 72 h of cytokine stimulation . 10 hg of total RNA was loaded per lane on a 0.8% agarose formaldehyde gel and transferred to nitrocellulose by Northern blotting. The filters were baked and hybridized for 12 h with a "P-labeled HIVLTR (HindIII-Aval) probe. Filters were washed and exposed to radiographic film . The labeled probe was removed from the filters by washing at 80°C in 0.1 x SSC, containing 0.1% SDS and then rehybridized with a "P-labeled /3-actin cDNA probe. The results were confirmed by RNA slot blot analysis (12) .
Nuclear Run-On Analysis. Nuclei from 5 x 10' U1 cells were isolated 17 h after cytokine stimulation and nuclear run-on analysis were performed according to a published procedure (38) . Briefly, equal amounts of '1P-labeled RNA (10' cpm/0.8 ml) were hybridized to linearized plasmid DNA probes immobilized on nitrocellulose filters. Probes included PBR 322 or PUC 19 as plasmid controls, pNL4-3, which is a plasmid containing a full-length HIV genome (39) , and human 0-actin cDNA . Filters were exposed to x-ray film for various times up to 7 d and densitometric laser scanning was performed on the different autoradiograms using an LKB 2222-10 densitometer. The densitometric measurements of HIV were normalized to those of the #-actin controls.
Results
Different Cytokines Upregulate HIV Replication in Acutely Infected Primary MDM. MDM cultures exposed to various concentrations of certain recombinant cytokines showed an increase in HIV replication. As previously reported (6), GM-CSF enhanced HIV production in primary infected MDM (Fig . 1 A) . Similarly, both TNT-a (Fig . 1 A) and IL6 (Fig.  1, A and B) were effective in upregulating HIV replication in MDM . Worthy of note is the fact that a significant degree of variability was observed between different monocyte donors in terms of susceptibility to HIV infection (with levels of peak HIV production in the absence of exogenous rytokine stimulation ranging between 300 and 12,000 rpm/Al), probably reflecting different levels of in vivo activation and/or differences in individual susceptibility to HIV infection, as previously observed for T lymphocytes (31) . Nonetheless, IIT6, and to a lesser extent TNF-a and GM-CSF, reproducibly increased HIV expression in MDM . 5 of 5 donors' infected Fig. 1 B. In contrast, IL6 did not show any significant effect on HIV infection of primary T lymphocytes either when cells were maintained in culture conditions similar to MDM or when stimulated with PHA, cultivated in the presence of 11,2, and infected with a T lymphocytotropic isolate of HIV (data not shown) .
Thus, IL6 represents a new HIVinductive cytokine for infected cells of the monorytic lineage, which have been previously described as important in vivo targets of infection (1) . Because of the broad range of susceptibilities to HIV infection observed with MDM obtained from different donors, we further investigated the inductive effects of IL6 on HIV expression by using the chronically infected monorytic cell line U1, which in our experience gave much more consistent results from experiment to experiment (32) (33) (34) . Similar to the primary infected macrophages, HIV expression is inducible in Ul cells by TNF-a (34, 35) and by GM-CSF (2) .
11,6 Induction of HIV Expression in Chronically Infected Promonocytic Cells. The chronically infected U1 cells were exposed to various concentrations (from 0 .1 to 1,000 U/ml) of rhIL6 ; cell viability and virus production were monitored daily up to 12 d after treatment with an individual cytokine. Maximal stimulation of HIV production was observed with 100 U/ml of IL6 occurring between 72 and 96 h after stimulation (Fig. 2) . As little as 1 U/ml of 11,6 was capable of inducing viral expression in U1 cells (Fig. 2) , whereas cytokine concentrations higher than 100 U/ml did not result in a further increase of HIV production . No cellular toxicity was observed in IL6-treated U1 cells at any IL6 concentrations tested, as determined by trypan blue dye exclusion criteria (>95% viable cells throughout the 7-d culture period) . Furthermore, 11,6 upregulated viral expression from U1 cells to levels comparable to those induced by TNF-ca (Fig. 2) and GM-CSF (not shown) . A second chronically infected promonorytic cell line, U33 .3, unlike U1 cells, constitutively expresses detectable amounts of virus (500-1,000 rpm/p.l of RT activity) (34) . HIV expression in U33 .3 cells was also inducible by IL6 and TNF-a (data not shown) . As we previously observed in infected primary T cells, IL6 (up to 1,000 U/ml) was not capable of affecting HIV production by the T lymphocytic cell line ACH-2 (data not shown) .
11,6 Synergizes with TNF-a in the Upregulation of HIV Expression in U1 Cells. Having established that multiple cytokines were capable individually of upregulating HIV expression in chronically infected promonocytic cells, we investigated the possibility that simultaneous stimulation of U1 cells with IL6 and TNF-ac (co-stimulation) could result in further increases in virus production . We observed that co-stimulation of these cells with 100 U/ml of IL6 and TNF-a resulted in a synergistic induction of HIV expression (Fig.  3 A) . Incubation of U1 cells for 72 h in the presence of 100 U/ml of 1176 and 100 U/ml of TNF-ac resulted in -65-fold stimulation (up to 100-fold in other experiments) of HIV expression over the constitutive levels, whereas individual incubation of U1 cells with the two cytokines led to a N10-fold RT increase (Fig. 3 A) . In addition to RT, both IL6 and TNF-a induced synthesis of specific HIV proteins that were virtually undetectable in unstimulated conditions, as determined by Western blot analysis (Fig. 3 B) . Co-stimulation of U1 cells with 100 U/ml each of IL-6 and TNF-a resulted in an increased intensity of the expressed bands as well as in the appearance of additional bands corresponding to s HIV proteins (Fig. 3 B) , reflecting the synergistic induction of RT activity in the culture supernatants . Suboptimal concentrations of IL6 (1 U/ml) were still effective in synergizing with TNF-ca . Both the direct and the synergistic effects of these rytokines on HIV expression were confirmed by indirect immunofluorescence and by neutralization studies which indicated that polyclonal and monoclonal anti-11r6 and anti-TNF-ca Ab were capable of suppressing both the direct and the synergistic effects of IL-6 and TNF-a stimulation on HIV expression (data not shown) .
We have also investigated whether combinations of cytokines could further enhance the levels of HIV replication in acutely infected primary MDM cultures, as compared with single cytokine treatments . We have not observed significant enhancement of HIV production in these cells by any combination of exogenous cytokines, thus far. However, it has been previously reported that HIV infection of MDM induces secretion of both TNF-ac (36, 40) and IL6 (27) , which could act both synergistically with exogenous cytokines as well as in an autocrine/paracrine manner (14, 15, 34, 41) , in maximizing the levels of HIV production in these culture conditions. In this regard, we have also observed production of IL6 in long-term (more than 30-d-old) MDM-infected cultures as well as reduced HIV replication in MDM treated with anti-IL-6 or antiTNF-a Ab (Poll, G ., J . S . Justement, A. Kinter, and A . S. Fauci, unpublished observations) .
IL6 Induction of Viral Expression in UI Cells Is Not Associated with Increased Levels ofSteady-State HIV RNA . To investigate whether induction of HIV expression by IL6 alone was mediated by an increased transcription of viral RNA, as previously demonstrated for TNF-a (11-13), we compared the 154 Interleukin 6 Induces Human Immunodeficiency Virus Expression levels of total HIV RNA present in U1 cells stimulated by these rytokines . TNF-a induced substantial amounts of HIV RNA (Fig. 4 A) , whereas IL6 did not induce a significant accumulation of HIV RNA over the constitutive levels . However, HIV protein expression was induced to comparable levels by 11,6 and TNF-a (Fig . 4 B) . In contrast, when U1 cells were co-stimulated with IL6 and TNF-ac, a synergistic accumulation of HIV RNA was observed in association with enhanced HIV protein production (Fig. 4, A and B) . RNA slot blot analysis confirmed both the lack of induction of HIV RNA following stimulation with IL-6 alone and the synergistic accumulation of viral RNA in U1 cells co-stimulated with IL6 and TNF-ca (data not shown) . Costimulation of U1 cells with 11,6 and TNF-ci resulted in a synergistic production of HIV p24 antigen that saturated the maximal optical capacity (equivalent to -400 ng/ml) of the ELISA reader.
11,6 and TNF-a Synergize at the Transcriptional Level to Upregulate HIV Expression. To determine whether the synergistic increase in HIV expression detectable at the protein, RT, and mRNA levels was correlated with an increased rate of HIV transcription, nuclear run-on analysis was performed on U1 cells stimulated with various cytokines alone or in combination. TNF-ci stimulation induced transcription of new HIV RNA three-fourfold over the unstimulated control, whereas 11,6 treatment alone did not significantly change the baseline transcriptional levels (Fig. 5) . However, costimulation of U1 cells with M.6 and TNF-a resulted in a synergistic increase of HIV transcription (N10-fold over the unstimulated controls) . To verify that these results were attributable to actual transcriptional changes, parallel experiments were performed with nuclei isolated from stimulated U1 cells that were incubated with the transcriptional inhibitor a-amanitin, which almost entirely suppressed transcription .
Discussion
In the present study we have demonstrated that the cytokine IL6, which plays an-important immunoregulatory role at multiple levels of the immune response (14, 15) , directly upregulates the production of HIV in primary infected MDM as well as in chronically infected monocytic cells. In contrast, IM was not effective in modulating either the susceptibility of primary T cells to HIV infection or the induction of virus expression in chronically infected T cell lines. In addition, IL6 synergizes in the induction of viral expression in U1 cells co-stimulated with TNF-a, which was previously described as a potent HIV inductive cytokine (3-5, 11-13, 34-36) . Synergy between cytokines is a well-recognized mechanism of modulation of the normal immune response (14, 41) . The present observation that certain of these cytokines can synergistically induce HIV expression in chronically infected cells indicates that HIV mimics the normal homeostatic mechanisms utilized by the immune system to upregulate its own gene expression. In this regard, cytokines such as IL6 and TNF-oi are known to function in an autocrine/paracrine manner to modulate the state of activation ofcertain immune competent cells (14, 15, 41) . Of interest, we have recently observed that TNF-a can induce expression ofHIV in chronically infected T lymphocytic and monocytic cells in an autocrine fashion (34) . We are currently investigating whether a similar mechanism is demonstrable for IL6.
At the molecular level, we and others have demonstrated that the inductive effect of TNF-ct on HIV expression involves the activation of the cellular transcription factor NFkB (10-13), which is a pleiotropic mediator of tissue-specific and cellular gene function (8, 9) . In contrast, IL6 stimulation induces expression of viral proteins and production of RT activity to levels comparable to that of TNF-a, but unlike TNF-a, does not increase significantly the levels ofsteadystate viral mRNA over the constitutive levels . However, costimulation of U1 cells with IL6 and TNF-a results in a synergistic enhancement of HIV expression measurable both at the RNA and at the protein/RT level. Nuclear run-on analysis demonstrates that this synergistic effect occurs, at least in part, at the transcriptional level. However, U1 stimulation with IL6 alone did not lead to a significant increase of HIV transcription . Therefore, it is likely that IL6 affects the expression of HIV by at least two mechanisms. In the presence ofTNF-cx, IL6 increases the levels ofviral transcripReferences tion and of steady-state RNA, resulting in a synergistic enhancement of HIV expression. In the absence of TNF-a, IL6 acts post-transcriptionally, increasing the expression of HIV proteins and RT activity without significantly inducing new transcription or accumulation of HIV RNA . In this regard, it has been recently shown that IL-6 can affect the synthesis of immunoglobulins at both the transcriptional and post-transcriptional level (42) .
The observation that IL6 upregulates the production of HIV in vitro both directly and in synergy with other cytokines provides a potential model to investigate the physiologic as well as pathogenic mechanisms that influence the degree of HIV expression in vivo. On the other hand, it has been reported recently that in vitro infection ofmonocytes with HIV induces synthesis and secretion of IL6 (27) . In fact, we have also observed IL6 production in infected primary macrophage cultures (Poli, G., J. S. Justement, A. Kinter, and A. S. Fauci, unpublished observations). Furthermore, increased levels of IL6 have been demonstrated both in the plasma (28) and in the cerebrospinal fluid (29) of HIVinfected individuals. Further understanding of the role of IL6 and other cytokines in the regulation ofHIV expression in infected cells may provide important insight into phenomena such as the progressive increase in HIV expression and ultimately viral burden that invariably occurs in infected individuals, and which are associated with deterioration of immune function and clinical progression towards AIDS (43).
